EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review)

Qing Nian, Yihui Li, Jingwei Li, Liyun Zhao, Fernando Rodrigues Lima, Jinhao Zeng, Rongxing Liu, Zhijun Ye

Oncology Reports · 16.11.2023 · 51 (1)

DOI: 10.3892/or.2023.8664 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 16.11.2023. Verfasst von Qing Nian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, P…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

U2 small nuclear RNA auxiliary factor 1 (U2AF1) is a multifunctional protein that plays a crucial role in the regulation of RNA splicing during eukaryotic gene expression. U2AF1 belongs to the SR family of splicing factors and is involved in the removal of introns from mRNAs and exon-exon binding. Mutations in U2AF1 are frequently observed in myelodysplastic syndrome, primary myelofibrosis, chronic myelomonocytic leukaemia, hairy cell leukaemia and other solid tumours, particularly in lung, pancreatic, and ovarian carcinomas. Therefore, targeting U2AF1 for therapeutic interventions may be a viable strategy for treating malignant diseases. In the present review, the pathogenic mechanisms associated with U2AF1 in different malignant diseases were summarized, and the potential of related targeting agents was discussed. Additionally, the feasibility of natural product-based therapies directed against U2AF1 was explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansSplicing Factor U2AFRNA Splicing FactorsRNA SplicingMutation

Stichwörter der Autor:innen

U2 small nuclear RNA auxiliary factor 1malignant diseasespliceosomestargeted therapy

Substanzen

Splicing Factor U2AFRNA Splicing FactorsU2AF1 protein, human

Autor:innen und Institutionen

  • Department of Transfusion, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, P.R. China.
  • Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100730, P.R. China.
  • Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technol…
  • Université Paris Cité, CNRS, Unité de Biologie Fonctionnelle et Adaptative, 75013 Paris, France.
  • Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610000, P.R. China.
  • Department of Pharmacy, The Second Affiliated Hospital, Army Medical University, Chongqing 400000, P.R. China.

Zitieren

APA

Nian, Q., Li, Y., Li, J., Zhao, L., Rodrigues Lima, F., Zeng, J., Liu, R., & Ye, Z. (2023). U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review). Oncology Reports, 51(1). https://doi.org/10.3892/or.2023.8664

Vancouver

Nian Q, Li Y, Li J, Zhao L, Rodrigues Lima F, Zeng J, et al. U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review). Oncology Reports. 2023;51(1). doi:10.3892/or.2023.8664

BibTeX
@article{Nian2023,
  author = {Nian, Qing and Li, Yihui and Li, Jingwei and Zhao, Liyun and Rodrigues Lima, Fernando and Zeng, Jinhao and Liu, Rongxing and Ye, Zhijun},
  title = {U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review)},
  journal = {Oncology Reports},
  year = {2023},
  volume = {51},
  number = {1},
  doi = {10.3892/or.2023.8664}
}
Kostenlos starten →